Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Other Non Operating Income (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Other Non Operating Income for 10 consecutive years, with $12000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 103.91% to $12000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15000.0 through Dec 2025, up 110.0% year-over-year, with the annual reading at -$27000.0 for FY2025, 82.0% up from the prior year.
  • Other Non Operating Income hit $12000.0 in Q4 2025 for vTv Therapeutics, up from -$34000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.9 million in Q2 2021 to a low of -$3.2 million in Q1 2022.
  • Historically, Other Non Operating Income has averaged -$14666.7 across 5 years, with a median of $14500.0 in 2023.
  • Biggest five-year swings in Other Non Operating Income: skyrocketed 281.44% in 2023 and later plummeted 1905.88% in 2024.
  • Year by year, Other Non Operating Income stood at $634000.0 in 2021, then increased by 14.35% to $725000.0 in 2022, then crashed by 97.66% to $17000.0 in 2023, then tumbled by 1905.88% to -$307000.0 in 2024, then skyrocketed by 103.91% to $12000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for VTVT at $12000.0 in Q4 2025, -$34000.0 in Q3 2025, and $54000.0 in Q2 2025.